Hematopoietic/Lymphoid Cancer Recruiting Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02685670Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaTreatment